Similarly, replication analysis using an independent NAFLD GWAS corroborated these findings, suggesting a potential adverse effect of GDF-15 on the risk of NAFLD (OR = 1.10; 95% CI = 1.01–1.20; p=0.037). The gene discussed is GDF15; the disease is metabolic dysfunction-associated steatotic liver disease.